In this textbased activity a leading expert discusses how to optimize HER3targeted therapy for patients with NSCLC with a focus on how to identify and mitigate HER3targeted therapyrelated adverse events
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/oncology/nsclc-her3-ae-management-1/26497-64031
- Start Date: 2024-12-05 06:00:00
- End Date: 2024-12-05 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Daiichi Sankyo, Inc. - Amount: 65140.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest